Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Nichols

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nursing|January 26, 2018
LettersKeʼshaun Vernon, Karen Nichols
Cytotherapy|January 1, 2016
Part 4: Interaction between unproven cellular therapies and global medicinal product approval regulatory frameworksKaren Nichols, William Janssen, Dominic Wall, et al.
Cytotherapy|June 15, 2019
Current state of U.S. Food and Drug Administration regulation for cellular and gene therapy products: potential cures on the horizonMichael Mendicino, Yong Fan, Deborah Griffin, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 17, 2006
One size does not fit all: using qualitative methods to inform the development of an Internet portal for multiple sclerosis patientsAshish Atreja, Neil Mehta, Deborah Miller, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|September 21, 2017
A New Community Health Center/Academic Medicine Partnership for Medicaid Cost Control, Powered by the Mega Teaching Health CenterRichard E Rieselbach, Ted Epperly, Aaron Friedman, et al.
Cytotherapy|November 16, 2010
Cell therapy medical tourism: time for actionKurt C Gunter, Arthur L Caplan, Chris Mason, et al.
Cytotherapy|November 22, 2015
Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy PerspectiveMassimo Dominici, Karen Nichols, Alok Srivastava, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nursing|January 26, 2018
LettersKeʼshaun Vernon, Karen Nichols
Cytotherapy|January 1, 2016
Part 4: Interaction between unproven cellular therapies and global medicinal product approval regulatory frameworksKaren Nichols, William Janssen, Dominic Wall, et al.
Cytotherapy|June 15, 2019
Current state of U.S. Food and Drug Administration regulation for cellular and gene therapy products: potential cures on the horizonMichael Mendicino, Yong Fan, Deborah Griffin, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 17, 2006
One size does not fit all: using qualitative methods to inform the development of an Internet portal for multiple sclerosis patientsAshish Atreja, Neil Mehta, Deborah Miller, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|September 21, 2017
A New Community Health Center/Academic Medicine Partnership for Medicaid Cost Control, Powered by the Mega Teaching Health CenterRichard E Rieselbach, Ted Epperly, Aaron Friedman, et al.
Cytotherapy|November 16, 2010
Cell therapy medical tourism: time for actionKurt C Gunter, Arthur L Caplan, Chris Mason, et al.
Cytotherapy|November 22, 2015
Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy PerspectiveMassimo Dominici, Karen Nichols, Alok Srivastava, et al.
Pageof 1